|
1
|
Mehlen P and Puisieux A: Metastasis: a
question of life or death. Nat Rev Cancer. 6:449–458. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
O’Shaughnessy J: Extending survival with
chemotherapy in metastatic breast cancer. Oncologist. 10(Suppl 3):
20–29. 2005.
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
4
|
Chang EL and Lo S: Diagnosis and
management of central nervous system metastases from breast cancer.
Oncologist. 8:398–410. 2003. View Article : Google Scholar
|
|
5
|
Lassman AB and DeAngelis LM: Brain
metastases. Neurol Clin. 21:1–23. 2003. View Article : Google Scholar
|
|
6
|
Rouault JP, Rimokh R, Tessa C, Paranhos G,
Ffrench M, Duret L, Garoccio M, Germain D, Samarut J and Magaud JP:
BTG1, a member of a new family of antiproliferative genes. EMBO J.
11:1663–1670. 1992.PubMed/NCBI
|
|
7
|
Berthet C, Guéhenneux F, Revol V, Samarut
C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP and Rouault JP:
Interaction of PRMT1 with BTG/TOB proteins in cell signalling:
molecular analysis and functional aspects. Genes Cells. 7:29–39.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsuda S, Rouault J, Magaud J and Berthet
C: In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS
Lett. 497:67–72. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bakker WJ, Blázquez-Domingo M, Kolbus A,
Besooyen J, Steinlein P, Beug H, Coffer PJ, Löwenberg B, von
Lindern M and van Dijk TB: FoxO3a regulates erythroid
differentiation and induces BTG1, an activator of protein arginine
methyl transferase 1. J Cell Biol. 164:175–184. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hata K, Nishijima K and Mizuguchi J: Role
for Btg1 and Btg2 in growth arrest of WEHI-231 cells through
arginine methylation following membrane immunoglobulin engagement.
Exp Cell Res. 313:2356–2366. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Corjay MH, Kearney MA, Munzer DA, Diamond
SM and Stoltenborg JK: Antiproliferative gene BTG1 is highly
expressed in apoptotic cells in macrophage-rich areas of advanced
lesions in Watanabe heritable hyperlipidemic rabbit and human. Lab
Invest. 78:847–858. 1998.PubMed/NCBI
|
|
12
|
Lee H, Cha S, Lee MS, Cho GJ, Choi WS and
Suk K: Role of antiproliferative B cell translocation gene-1 as an
apoptotic sensitizer in activation-induced cell death of brain
microglia. J Immunol. 171:5802–5811. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rodier A, Marchal-Victorion S, Rochard P,
Casas F, Cassar-Malek I, Rouault JP, Magaud JP, Mason DY, Wrutniak
C and Cabello G: BTG1: a triiodothyronine target involved in the
myogenic influence of the hormone. Exp Cell Res. 249:337–348. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cho JW, Kim JJ, Park SG, Lee DH, Lee SC,
Kim HJ, Park BC and Cho S: Identification of B-cell translocation
gene 1 as a biomarker for monitoring the remission of acute myeloid
leukemia. Proteomics. 4:3456–3463. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Poste G and Fidler IJ: The pathogenesis of
cancer metastasis. Nature. 283:139–146. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Leber MF and Efferth T: Molecular
principles of cancer invasion and metastasis (review). Int J Oncol.
34:881–895. 2009.PubMed/NCBI
|
|
17
|
Woodhouse EC, Chuaqui RF and Liotta LA:
General mechanisms of metastasis. Cancer. 80(8 Suppl): 1529–1537.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Silletti S, Paku S and Raz A: Tumor cell
motility and metastasis: Autocrine motility factor as an example of
ecto/exoenzyme cytokines. Pathol Oncol Res. 3:230–254. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC,
Yang J and Yao Z: Effects of raf kinase inhibitor protein
expression on metastasis and progression of human breast cancer.
Mol Cancer Res. 7:832–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liotta LA and Stracke ML: Tumor invasion
and metastases: biochemical mechanisms. Cancer Treat Res.
40:223–238. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Trojanek J: Matrix metalloproteinases and
their tissue inhibitors. Postepy Biochem. 58:353–362. 2012.(In
Polish).
|
|
22
|
Bussemakers MJ, van Moorselaar RJ, Giroldi
LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM and Schalken JA:
Decreased expression of E-cadherin in the progression of rat
prostatic cancer. Cancer Res. 52:2916–2922. 1992.PubMed/NCBI
|
|
23
|
Tanigawa N, Amaya H, Matsumura M and
Shimomatsuya T: Association of tumour vasculature with tumour
progression and overall survival of patients with non-early gastric
carcinomas. Br J Cancer. 75:566–571. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gasparini G: Clinical significance of the
determination of angiogenesis in human breast cancer: update of the
biological background and overview of the Vicenza studies. Eur J
Cancer. 32A:2485–2493. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karaiossifidi H, Kouri E, Arvaniti H,
Sfikas S and Vasilaros S: Tumor angiogenesis in node-negative
breast cancer: relationship with relapse free survival. Anticancer
Res. 16:4001–4002. 1996.PubMed/NCBI
|
|
26
|
Heimann R, Ferguson D, Powers C, Recant
WM, Weichselbaum RR and Hellman S: Angiogenesis as a predictor of
long-term survival for patients with node-negative breast cancer. J
Natl Cancer Inst. 88:1764–1769. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Silberman MA, Partin AW, Veltri RW and
Epstein JI: Tumor angiogenesis correlates with progression after
radical prostatectomy but not with pathologic stage in Gleason sum
5 to 7 adenocarcinoma of the prostate. Cancer. 79:772–779. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Obermair A, Kohlberger P, Bancher-Todesca
D, Tempfer C, Sliutz G, Leodolter S, Reinthaller A, Kainz C,
Breitenecker G and Gitsch G: Influence of microvessel density and
vascular permeability factor/vascular endothelial growth factor
expression on prognosis in vulvar cancer. Gynecol Oncol.
63:204–209. 1996. View Article : Google Scholar
|
|
29
|
Srivastava A, Laidler P, Davies RP, Horgan
K and Hughes LE: The prognostic significance of tumor vascularity
in intermediate-thickness (0.76–4.0 mm thick) skin melanoma. A
quantitative histologic study. Am J Pathol. 133:419–423. 1988.
|
|
30
|
Denijn M and Ruiter DJ: The possible role
of angiogenesis in the metastatic potential of human melanoma.
Clinicopathological aspects. Melanoma Res. 3:5–14. 1993. View Article : Google Scholar : PubMed/NCBI
|
